phase 3 trials ongoing as of 2025 Best phase 2 weight loss (retatrutide) / 24.2% at 48 weeks, 12 mg dose Best phase 3 weight loss (tirzepatide) / 22.5% at 72 weeks, 15 mg dose Combination evidence / zero published controlled trials Primary combination risk / additive nausea, vomiting, potential pancreatitis Switching rationale / inadequate response or tolerability on tirzepatide Guideline position on combining / no major guideline endorses dual-incretin stacking What Are Mounjaro and Retatrutide, and How Do They Differ
If you are self-injecting retatrutide and do not have assistance, the upper arm is generally not recommended as a primary site
Obexelimab in Systemic Lupus Erythematosus With Exploration of Response Based on Gene Pathway Co-Expression Patterns: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial
10.1128/spectrum.01601-24 180 SunS
This ingredient has been found safe for cosmetics with the data showing no irritation or sensitization
From a clinical standpoint, peptides play an important role in areas like metabolic health, hormone balance, and weight management
